NEW YORK (GenomeWeb) – Roswell Park Cancer Institute today said that the New York State Department of Health has granted approval for the institute to test cancer patients using its OmniSeq Target molecular diagnostic test.
NEW YORK (GenomeWeb) – The board of directors of New York State's development agency has approved $105 million in funding to establish the NYS Genomic Medicine and Big Data Center (GMBDC), a genomics data partnership that will connect institutions in Buffalo with the New York Genome Center, Gov.
NEW YORK (GenomeWeb News) – Roswell Park Cancer Institute is investing $18.5 million to fund the launch of a new Center for Personalized Medicine (CPM) at its campus in Buffalo, according to the office of NY Governor Andrew Cuomo.
Exiqon said today that it has signed a "center of excellence" agreement with the Roswell Park Cancer Institute.
Under the agreement, Buffalo, NY-based RPCI will provide real-time PCR services using Exiqon's Mircury LNA Universal RT microRNA PCR products.